Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation.

Kasperkiewicz, Michael; Strong, Rebecca; Yale, Marc; Dunn, Patrick; Woodley, David T

Kasperkiewicz, Michael; Strong, Rebecca; Yale, Marc; Dunn, Patrick; Woodley, David T.

Kasperkiewicz M; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Strong R; International Pemphigus and Pemphigoid Foundation, Roseville, California, USA.
Yale M; International Pemphigus and Pemphigoid Foundation, Roseville, California, USA.
Dunn P; International Pemphigus and Pemphigoid Foundation, Roseville, California, USA.
Woodley DT; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

J Eur Acad Dermatol Venereol ; 2022 Aug 14.

Article in English | MEDLINE | ID: covidwho-2242028

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Randomized controlled trials Topics: Vaccines Language: English Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18493

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google